Welcome to Paid Research Studies

  • Condition:   Healthy Subjects
    Intervention:   Drug: VNRX-5133 + cefepime
    Sponsors:   VenatoRx Pharmaceuticals, Inc.;   National Institutes of Health (NIH)

  • Conditions:   Intestinal Microbiome;   Febrile Neutropenia
    Interventions:   Drug: Piperacillin-tazobactam;   Drug: cefepime
    Sponsor:   Memorial Sloan Kettering Cancer Center

  • Condition:   Other Infectious Diseases
    Interventions:   Drug: Ceftolozane-Tazobactam;   Drug: Cefepime;   Drug: Meropenem;   Drug: Piperacillin/Tazobactam
    Sponsors:   M.D. Anderson Cancer Center;   Merck Sharp & Dohme Corp.

  • Condition:   Urinary Tract Infections
    Interventions:   Drug: cefepime/AAI101 combination;   Drug: Piperacillin/tazobactam
    Sponsors:   Allecra;   Medpace, Inc.

  • Condition:   Pneumonia
    Interventions:   Drug: Murepavadin;   Drug: Two anti-pseudomonal antibiotics
    Sponsor:   Polyphor Ltd.

  • Conditions:   Adenovirus;   Anesthesia;   Anxiety;   Anxiolysis;   Autism;   Autistic Disorder;   Bacterial Meningitis;   Bacterial Septicemia;   Benzodiazepine;   Bipolar Disorder;   Bone and Joint Infections;   Central Nervous System Infections;   Convulsions;   Cytomegalovirus Retinitis;   Early-onset Schizophrenia Spectrum Disorders;   Epilepsy;   General Anesthesia;   Gynecologic Infections;   Herpes Simplex Virus;   Infantile Hemangioma;   Infection;   Inflammation;   Inflammatory Conditions;   Intra-abdominal Infections;   Lower Respiratory Tract Infections;   Migraines;   Pain;   Pneumonia;   Schizophrenia;   Sedation;   Seizures;   Skeletal Muscle Spasms;   Skin and Skin-structure Infections;   Thromboprophylaxis;   Thrombosis;   Treatment-resistant Schizophrenia;   Urinary Tract Infections;   Withdrawal;   Sepsis;   Gram-negative Infection;   Bradycardia;   Cardiac Arrest;   Cardiac Arrhythmia;   Staphylococcal Infections;   Nosocomial Pneumonia;   Neuromuscular Blockade;   Methicillin Resistant Staphylococcus Aureus;   Endocarditis;   Neutropenia;   Headache
    Intervention:   Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
    Sponsors:   Daniel Benjamin;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   The EMMES Corporation